Published In
Archives of Rheumatology
Volume 33 · Issue 3 · September 2018
Pages: 372-375
History
Published Online: September 30, 2018
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ben JACOBS
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom
Ali JAWAD
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom
Zozik FATTAH
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom
Ben JACOBS, Ali JAWAD, & Zozik FATTAH. (2018). Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab. Archives of Rheumatology, 33(3), 372–375. https://doi.org/10.5606/ArchRheumatol.2018.6668
Abstract
In this article, we report a case of pneumatosis intestinalis associated with tocilizumab use. This is a unique case and may explain the increased rate of idiopathic bowel perforation among patients taking tocilizumab.
Similar Articles
Article Info
Published In
Journal
Archives of Rheumatology
Volume / Issue
Volume 33 · Issue 3 · September 2018
Pages
372-375
History
Published Online
September 30, 2018
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Affiliations
1
Ben JACOBS
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom
2
Ali JAWAD
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom
3
Zozik FATTAH
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom
Cite this Article
Ben JACOBS, Ali JAWAD, & Zozik FATTAH. (2018). Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab. Archives of Rheumatology, 33(3), 372–375. https://doi.org/10.5606/ArchRheumatol.2018.6668
Outlines